DXCM - Stock Price ChartPeers: ABT MDT TNDM PODD BSX SENS GMED ZBH SYK TDOC | Held by: VTI VOO VO QQQ SPY VUG IVV VOT XLV IWP Scroll to Statements Index NDX, S&P 500 P/E 49.68 EPS (ttm) 1.42 Insider Own 1.40% Shs Outstand 390.70M Perf Week 2.98% Market Cap 27.75B Forward ...
Plus, access to 150 markets across 34 countries and the Zacks Rank Trading Tool. Open An Account View Disclosure Dexcom Inc Competitors - Telecommunications Equipment Company Price USD Returns 1-YEAR RETURNS 5-year Abbott Laboratories ABT $129.38 23.21% 8.37% Thermo Fisher Scientific Inc. TMO $...
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The Zacks Rank sy...
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Instruments is currently in the top 41% of the 250 plus Zacks industries. Our research shows that ...
DXCM Stock USD 70.22 0.04 0.06% Our overall analysis of DexCom's news coverage and content from conventional and social sources shows investors' bearish mood towards DexCom Inc. The specific impact of DexCom news on its stock price will depend on a range of factors, including the nature and...
ET on Zacks.com BTIG Adjusts DexCom (DXCM) Price Target Ahead of MedTech Q1 Results | DXCM Stock News Apr. 14, 2025 at 10:15 a.m. ET on GuruFocus.com DexCom price target lowered to $107 from $120 at BTIG Apr. 14, 2025 at 8:57 a.m. ET on TipRanks.com BTIG Remains...
ET on Zacks.com Optimistic Buy Rating for Dexcom Despite FDA Warning Letter Mar. 13, 2025 at 2:26 a.m. ET on TipRanks.com Dexcom’s CFO Makes a Significant Stock Sale Mar. 11, 2025 at 10:11 p.m. ET on TipRanks.com Analysts Are Bullish on Top Healthcare Stocks: Achieve ...
the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Instruments is currently in the top 34% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to ...
Momentum investors should take note of this Medical stock. DXCM has a Momentum Style Score of A, and shares are up 8% over the past four weeks. For fiscal 2024, seven analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.02...
DexCom, Inc. (DXCM) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc....